ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Patent Owner
Stats
- 30 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Aug 16, 2016 most recent publication
Details
- 30 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 419 Total Citation Count
- Jul 16, 1997 Earliest Filing
- 55 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0374,288 SYSTEM AND METHOD FOR DETECTING AN ENDO-URETHRAL DEVICE FOR AN ARTIFICIAL SPHINCTER THAT IS IMPLANTABLE IN AN ANIMAL OR HUMAN BODYJan 31, 14Dec 31, 15[A61F, A61B]
2012/0225,947 RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNITSep 23, 10Sep 06, 12[A61K, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9416392 Diagnosis of bacterial meningitis based on the measure of ROS production in a sample of cerebrospinal fluidJul 26, 11Aug 16, 16[C12Q, G01N]
9340819 Method for detecting the presence of carbapenemase-producing bacteria in a sampleJun 21, 12May 17, 16[C12Q]
9297046 TET2 as a new diagnostic and pronostic marker in hematopoietic neoplasmsMar 21, 12Mar 29, 16[C12Q]
9272054 Agents for the molecular imaging of serine-protease in human pathologiesDec 05, 11Mar 01, 16[A61K, A61M]
9233144 Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancerSep 18, 09Jan 12, 16[A61K, C12Q, C12N, G01N, C07K]
9198949 Method and pharmaceutical composition for use in the treatment of cancerJun 06, 13Dec 01, 15[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0136,103 Pharmaceutical Composition in the Form of Granules for the Treatment of Metabolic Disorders in ChildrenAbandonedJun 26, 14May 19, 16[A61K]
2015/0323,550 METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSIONAbandonedApr 14, 15Nov 12, 15[G01N]
2015/0276,760 Method for Screening a Compound Capable of Inhibiting the Notch1 Transcriptional ActivityAbandonedOct 04, 12Oct 01, 15[A61K, G01N]
2015/0247,196 IN VITRO GENETIC DIAGNOSTIC OF INHERITED NEUROMUSCULAR DISORDERSAbandonedSep 06, 13Sep 03, 15[C12Q]
2015/0197,574 USE OF TRANSFERRIN RECEPTOR ANTAGONIST FOR THE TREATMENT OF THALASSEMIAAbandonedAug 02, 13Jul 16, 15[C07K]
2015/0184,155 METHODS FOR PREVENTING AND TREATING CHRONIC KIDNEY DISEASE (CKD)AbandonedJul 18, 13Jul 02, 15[C12N, C07K]
2015/0140,043 IMMUNOMODULATORY METHODS USING NOTCH AGONISTSAbandonedMay 07, 13May 21, 15[A61K, C12Q, G01N]
2015/0126,573 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedMay 07, 13May 07, 15[A61K, G01N]
2015/0105,329 Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ DamageAbandonedMar 26, 13Apr 16, 15[A61K]
2015/0031,569 Mutations of the GPR179 Gene in Congenital Stationary Night BlindnessAbandonedJan 23, 13Jan 29, 15[C12Q, G01N, C07K]
2014/0371,082 PROCESS AND APPARATUS FOR QUANTIFYING NUCLEIC ACID IN A SAMPLEAbandonedJul 02, 12Dec 18, 14[C12Q]
2014/0335,119 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUALAbandonedMay 23, 14Nov 13, 14[A61K, C12N, C07K]
2014/0286,967 Methods for the Treatment and the Prognostic Assessment of Malignant Pleural MesotheliomaAbandonedJun 06, 14Sep 25, 14[C07K]
2014/0199,379 COMPOSITIONS HAVING MEANS FOR TARGETING AT LEAST ONE ANTIGEN TO DENDRITIC CELLSAbandonedJul 23, 12Jul 17, 14[A61K]
2014/0018,643 SELF-CONTAINED SYSTEM SUITABLE FOR BEING INSERTED INTO AN ANATOMICAL CAVITYAbandonedJan 20, 12Jan 16, 14[A61B]
2013/0331,291 METHOD FOR PREDICTING THE OUTCOME OF COLON CANCER BY ANALYSING MIRNA EXPRESSIONAbandonedDec 01, 11Dec 12, 13[C12Q]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
